메뉴 건너뛰기




Volumn 55, Issue 3, 2016, Pages 152-158

Retinal Vein Occlusions: Therapeutic Switch in Macular Oedema Treatment with a 12-Month Follow-Up

Author keywords

Antivascular endothelial growth factor agent; Bevacizumab; Intravitreal dexamethasone implant; Retinal vein occlusion; Switch

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; ANGIOGENESIS INHIBITOR; DRUG IMPLANT; GLUCOCORTICOID;

EID: 84954432448     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000442258     Document Type: Article
Times cited : (13)

References (54)
  • 1
    • 80051776549 scopus 로고    scopus 로고
    • The burden of disease of retinal vein occlusion: Review of the literature
    • Laouri M, Chen E, Looman M, Gallagher M: The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond) 2011; 25: 981-988.
    • (2011) Eye (Lond) , vol.25 , pp. 981-988
    • Laouri, M.1    Chen, E.2    Looman, M.3    Gallagher, M.4
  • 3
    • 77956470220 scopus 로고    scopus 로고
    • Retinal vein thrombosis: Pathogenesis and management
    • Rehak M, Wiedemann P: Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010; 8: 1886-1894.
    • (2010) J Thromb Haemost , vol.8 , pp. 1886-1894
    • Rehak, M.1    Wiedemann, P.2
  • 4
    • 0028509443 scopus 로고
    • Retinal vein occlusion
    • Hayreh SS: Retinal vein occlusion. Indian J Ophthalmol 1994; 42: 109-132.
    • (1994) Indian J Ophthalmol , vol.42 , pp. 109-132
    • Hayreh, S.S.1
  • 5
    • 0021241936 scopus 로고
    • Macular edema secondary to occlusion of the retinal veins
    • Gutman FA, Zegarra H: Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 1984; 28(suppl):462-470.
    • (1984) Surv Ophthalmol , vol.28 , pp. 462-470
    • Gutman, F.A.1    Zegarra, H.2
  • 6
    • 17444394528 scopus 로고    scopus 로고
    • Prevalent misconceptions about acute retinal vascular occlusive disorders
    • Hayreh SS: Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005; 24: 493-519.
    • (2005) Prog Retin Eye Res , vol.24 , pp. 493-519
    • Hayreh, S.S.1
  • 7
    • 77949517306 scopus 로고    scopus 로고
    • Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item national eye institute visual function questionnaire
    • Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S: Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Br J Ophthalmol 2010; 94: 319-323.
    • (2010) Br J Ophthalmol , vol.94 , pp. 319-323
    • Awdeh, R.M.1    Elsing, S.H.2    Deramo, V.A.3    Stinnett, S.4    Lee, P.P.5    Fekrat, S.6
  • 9
    • 84878753529 scopus 로고    scopus 로고
    • Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion
    • Pfister M, Rothweiler F, Michaelis M, Cinatl J Jr, Schubert R, Koch FH, Koss MJ: Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion. Clin Ophthalmol 2013; 7: 1061-1067.
    • (2013) Clin Ophthalmol , vol.7 , pp. 1061-1067
    • Pfister, M.1    Rothweiler, F.2    Michaelis, M.3    Cinatl, J.4    Schubert, R.5    Koch, F.H.6    Koss, M.J.7
  • 10
    • 0021221946 scopus 로고
    • Argon laser photocoagulation for macular edema in branch vein occlusion
    • The Branch Vein Occlusion Study Group
    • Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984; 98: 271-282.
    • (1984) Am J Ophthalmol , vol.98 , pp. 271-282
  • 11
    • 79958787885 scopus 로고    scopus 로고
    • Treatment of macular edema due to retinal vein occlusions
    • Channa R, Smith M, Campochiaro PA: Treatment of macular edema due to retinal vein occlusions. Clin Ophthalmol 2011; 5: 705-713.
    • (2011) Clin Ophthalmol , vol.5 , pp. 705-713
    • Channa, R.1    Smith, M.2    Campochiaro, P.A.3
  • 12
    • 84860174253 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor treatment for retinal vein occlusions
    • Campochiaro PA: Anti-vascular endothelial growth factor treatment for retinal vein occlusions. Ophthalmologica 2012; 227(suppl 1): 30-35.
    • (2012) Ophthalmologica , vol.227 , pp. 30-35
    • Campochiaro, P.A.1
  • 13
    • 84867100215 scopus 로고    scopus 로고
    • Improved visionrelated function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE trials
    • BRAVO and CRUISE Study Groups
    • Varma R, Bressler NM, Suner I, Lee P, Dolan CM, Ward J, Colman S, Rubio RG; BRAVO and CRUISE Study Groups: Improved visionrelated function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2012; 119: 2108-2118.
    • (2012) Ophthalmology , vol.119 , pp. 2108-2118
    • Varma, R.1    Bressler, N.M.2    Suner, I.3    Lee, P.4    Dolan, C.M.5    Ward, J.6    Colman, S.7    Rubio, R.G.8
  • 14
    • 77952891051 scopus 로고    scopus 로고
    • Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study
    • BRAVO Investigators
    • Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; BRAVO Investigators: Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1102-1112.
    • (2010) Ophthalmology , vol.117 , pp. 1102-1112
    • Campochiaro, P.A.1    Heier, J.S.2    Feiner, L.3    Gray, S.4    Saroj, N.5    Rundle, A.C.6    Murahashi, W.Y.7    Rubio, R.G.8
  • 16
    • 33749632278 scopus 로고    scopus 로고
    • Development of ranibizumab, an antivascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
    • Ferrara N, Damico L, Shams N, Lowman H, Kim R: Development of ranibizumab, an antivascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 2006; 26: 859-870.
    • (2006) Retina , vol.26 , pp. 859-870
    • Ferrara, N.1    Damico, L.2    Shams, N.3    Lowman, H.4    Kim, R.5
  • 17
    • 84885004807 scopus 로고    scopus 로고
    • Bevacizumab for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis
    • Lu Y, Su L, Xu X: Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. J Ocul Pharmacol Ther 2013; 29: 702-708.
    • (2013) J Ocul Pharmacol Ther , vol.29 , pp. 702-708
    • Lu, Y.1    Su, L.2    Xu, X.3
  • 18
    • 36248981014 scopus 로고    scopus 로고
    • Early bevacizumab treatment of central retinal vein occlusion
    • Ferrara DC, Koizumi H, Spaide RF: Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007; 144: 864-871.
    • (2007) Am J Ophthalmol , vol.144 , pp. 864-871
    • Ferrara, D.C.1    Koizumi, H.2    Spaide, R.F.3
  • 19
    • 84880099506 scopus 로고    scopus 로고
    • Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions
    • Singer MA, Cohen SR, Groth SL, Porbandarwalla S: Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions. Clin Ophthalmol 2013; 7: 1377-1383.
    • (2013) Clin Ophthalmol , vol.7 , pp. 1377-1383
    • Singer, M.A.1    Cohen, S.R.2    Groth, S.L.3    Porbandarwalla, S.4
  • 20
    • 34247231572 scopus 로고    scopus 로고
    • Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease
    • Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA: Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007; 27: 426-431.
    • (2007) Retina , vol.27 , pp. 426-431
    • Matsumoto, Y.1    Freund, K.B.2    Peiretti, E.3    Cooney, M.J.4    Ferrara, D.C.5    Yannuzzi, L.A.6
  • 21
    • 79958281477 scopus 로고    scopus 로고
    • Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion
    • Yasuda S, Kondo M, Kachi S, Ito Y, Terui T, Ueno S, Terasaki H: Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 2011; 31: 1075-1082.
    • (2011) Retina , vol.31 , pp. 1075-1082
    • Yasuda, S.1    Kondo, M.2    Kachi, S.3    Ito, Y.4    Terui, T.5    Ueno, S.6    Terasaki, H.7
  • 22
    • 84903696227 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections
    • Alshareef RA, Garg SJ, Hsu J, Vander J, Park C, Spirn MJ: Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections. J Ocul Pharmacol Ther 2014; 30: 512-516.
    • (2014) J Ocul Pharmacol Ther , vol.30 , pp. 512-516
    • Alshareef, R.A.1    Garg, S.J.2    Hsu, J.3    Vander, J.4    Park, C.5    Spirn, M.J.6
  • 23
    • 84923447617 scopus 로고    scopus 로고
    • Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
    • Yoo SG, Kim JH, Lee TG, Kim CG, Kim JW: Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab. Indian J Ophthalmol 2015; 63: 25-29.
    • (2015) Indian J Ophthalmol , vol.63 , pp. 25-29
    • Yoo, S.G.1    Kim, J.H.2    Lee, T.G.3    Kim, C.G.4    Kim, J.W.5
  • 24
    • 84928491964 scopus 로고    scopus 로고
    • The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion
    • Lehmann-Clarke L, Dirani A, Mantel I, Ambresin A: The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion. Klin Monatsbl Augenheilkd 2015; 232: 552-555.
    • (2015) Klin Monatsbl Augenheilkd , vol.232 , pp. 552-555
    • Lehmann-Clarke, L.1    Dirani, A.2    Mantel, I.3    Ambresin, A.4
  • 25
    • 84878899977 scopus 로고    scopus 로고
    • Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion
    • Sharareh B, Gallemore R, Taban M, Onishi S, Wallsh J: Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion. Retina 2013; 33: 1227-1231.
    • (2013) Retina , vol.33 , pp. 1227-1231
    • Sharareh, B.1    Gallemore, R.2    Taban, M.3    Onishi, S.4    Wallsh, J.5
  • 26
    • 16844384965 scopus 로고    scopus 로고
    • Foveal avascular zone in diabetic retinopathy: Quantitative vs qualitative assessment
    • Conrath J, Giorgi R, Raccah D, Ridings B: Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment. Eye (Lond) 2005; 19: 322-326.
    • (2005) Eye (Lond) , vol.19 , pp. 322-326
    • Conrath, J.1    Giorgi, R.2    Raccah, D.3    Ridings, B.4
  • 27
    • 84877763395 scopus 로고    scopus 로고
    • Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography
    • Bhisitkul RB, Campochiaro PA, Shapiro H, Rubio RG: Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology 2013; 120: 1057-1063.
    • (2013) Ophthalmology , vol.120 , pp. 1057-1063
    • Bhisitkul, R.B.1    Campochiaro, P.A.2    Shapiro, H.3    Rubio, R.G.4
  • 28
  • 29
    • 79958843614 scopus 로고    scopus 로고
    • Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: Twelve-month outcomes of a phase III study
    • Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG: Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011; 118: 2041-2049.
    • (2011) Ophthalmology , vol.118 , pp. 2041-2049
    • Campochiaro, P.A.1    Brown, D.M.2    Awh, C.C.3    Lee, S.Y.4    Gray, S.5    Saroj, N.6    Murahashi, W.Y.7    Rubio, R.G.8
  • 31
    • 84873738185 scopus 로고    scopus 로고
    • Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 Copernicus Study
    • e427
    • Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, Zeitz O, Sandbrink R, Zhu X, Haller JA: Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 Copernicus Study. Am J Ophthalmol 2013; 155: 429-437 e427.
    • (2013) Am J Ophthalmol , vol.155 , pp. 429-437
    • Brown, D.M.1    Heier, J.S.2    Clark, W.L.3    Boyer, D.S.4    Vitti, R.5    Berliner, A.J.6    Zeitz, O.7    Sandbrink, R.8    Zhu, X.9    Haller, J.A.10
  • 32
    • 84870708962 scopus 로고    scopus 로고
    • Benefit from bevacizumab for macular edema in central retinal vein occlusion: Twelve-month results of a prospective, randomized study
    • Epstein DL, Algvere PV, von Wendt G, Seregard S, Kvanta A: Benefit from bevacizumab for macular edema in central retinal vein occlusion: Twelve-month results of a prospective, randomized study. Ophthalmology 2012; 119: 2587-2591.
    • (2012) Ophthalmology , vol.119 , pp. 2587-2591
    • Epstein, D.L.1    Algvere, P.V.2    Von Wendt, G.3    Seregard, S.4    Kvanta, A.5
  • 33
    • 84862817252 scopus 로고    scopus 로고
    • Ranibizumab for macular edema due to retinal vein occlusions: Longterm follow-up in the horizon trial
    • Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P: Ranibizumab for macular edema due to retinal vein occlusions: longterm follow-up in the horizon trial. Ophthalmology 2012; 119: 802-809.
    • (2012) Ophthalmology , vol.119 , pp. 802-809
    • Heier, J.S.1    Campochiaro, P.A.2    Yau, L.3    Li, Z.4    Saroj, N.5    Rubio, R.G.6    Lai, P.7
  • 34
    • 84867100215 scopus 로고    scopus 로고
    • Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: Results from the BRAVO and CRUISE trials
    • Varma R, Bressler NM, Suner I, Lee P, Dolan CM, Ward J, Colman S, Rubio RG: Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2011; 119: 2108-2118.
    • (2011) Ophthalmology , vol.119 , pp. 2108-2118
    • Varma, R.1    Bressler, N.M.2    Suner, I.3    Lee, P.4    Dolan, C.M.5    Ward, J.6    Colman, S.7    Rubio, R.G.8
  • 35
    • 84937738744 scopus 로고    scopus 로고
    • A randomised, doublemasked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL report No 1
    • Narayanan R, Panchal B, Das T, Chhablani J, Jalali S, Ali MH: A randomised, doublemasked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL report No 1. Br J Ophthalmol 2015; 99: 954-959.
    • (2015) Br J Ophthalmol , vol.99 , pp. 954-959
    • Narayanan, R.1    Panchal, B.2    Das, T.3    Chhablani, J.4    Jalali, S.5    Ali, M.H.6
  • 37
    • 84928481233 scopus 로고    scopus 로고
    • Recurrent macular edema in central retinal vein occlusion treated with intravitreal ranibizumab using a modified treat and extend regimen
    • Dirani A, Mantel I, Ambresin A: Recurrent macular edema in central retinal vein occlusion treated with intravitreal ranibizumab using a modified treat and extend regimen. Klin Monatsbl Augenheilkd 2015; 232: 538-541.
    • (2015) Klin Monatsbl Augenheilkd , vol.232 , pp. 538-541
    • Dirani, A.1    Mantel, I.2    Ambresin, A.3
  • 38
    • 84940608056 scopus 로고    scopus 로고
    • Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion
    • Kim M, Lee DH, Byeon SH, Koh HJ, Kim SS, Lee SC: Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion. Br J Ophthalmol 2015; 99: 1271-1276.
    • (2015) Br J Ophthalmol , vol.99 , pp. 1271-1276
    • Kim, M.1    Lee, D.H.2    Byeon, S.H.3    Koh, H.J.4    Kim, S.S.5    Lee, S.C.6
  • 40
    • 84895073440 scopus 로고    scopus 로고
    • Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (SHASTA Study)
    • Capone A Jr, Singer MA, Dodwell DG, Dreyer RF, Oh KT, Roth DB, Walt JG, Scott LC, Hollander DA: Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (SHASTA Study). Retina 2014; 34: 342-351.
    • (2014) Retina , vol.34 , pp. 342-351
    • Capone, A.1    Singer, M.A.2    Dodwell, D.G.3    Dreyer, R.F.4    Oh, K.T.5    Roth, D.B.6    Walt, J.G.7    Scott, L.C.8    Hollander, D.A.9
  • 42
    • 67749106387 scopus 로고    scopus 로고
    • Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration
    • Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT: Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina 2009; 29: 723-731.
    • (2009) Retina , vol.29 , pp. 723-731
    • Forooghian, F.1    Cukras, C.2    Meyerle, C.B.3    Chew, E.Y.4    Wong, W.T.5
  • 43
    • 56549111386 scopus 로고    scopus 로고
    • Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in agerelated macular degeneration?
    • Schaal S, Kaplan HJ, Tezel TH: Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in agerelated macular degeneration? Ophthalmology 2008; 115: 2199-2205.
    • (2008) Ophthalmology , vol.115 , pp. 2199-2205
    • Schaal, S.1    Kaplan, H.J.2    Tezel, T.H.3
  • 45
    • 77956113448 scopus 로고    scopus 로고
    • Retinal vein occlusion: Pathophysiology and treatment options
    • Karia N: Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol 2010; 4: 809-816.
    • (2010) Clin Ophthalmol , vol.4 , pp. 809-816
    • Karia, N.1
  • 47
    • 42449092862 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas
    • Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC: Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 2008; 57: 1026-1033.
    • (2008) Diabetes , vol.57 , pp. 1026-1033
    • Zhang, X.1    Bao, S.2    Lai, D.3    Rapkins, R.W.4    Gillies, M.C.5
  • 48
    • 78751647835 scopus 로고    scopus 로고
    • Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema
    • Goel N, Kumar V, Ghosh B: Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema. Int Ophthalmol 2011; 31: 39-42.
    • (2011) Int Ophthalmol , vol.31 , pp. 39-42
    • Goel, N.1    Kumar, V.2    Ghosh, B.3
  • 50
    • 84875752725 scopus 로고    scopus 로고
    • Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion
    • Campochiaro PA, Bhisitkul RB, Shapiro H, Rubio RG: Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology 2012; 120: 795-802.
    • (2012) Ophthalmology , vol.120 , pp. 795-802
    • Campochiaro, P.A.1    Bhisitkul, R.B.2    Shapiro, H.3    Rubio, R.G.4
  • 51
    • 84859710188 scopus 로고    scopus 로고
    • The inner segment/outer segment junction: What have we learnt so far?
    • Wong IY, Iu LP, Koizumi H, Lai WW: The inner segment/outer segment junction: what have we learnt so far? Curr Opin Ophthalmol 2012; 23: 210-218.
    • (2012) Curr Opin Ophthalmol , vol.23 , pp. 210-218
    • Wong, I.Y.1    Iu, L.P.2    Koizumi, H.3    Lai, W.W.4
  • 52
    • 84863874008 scopus 로고    scopus 로고
    • SCORE Study Research Group: Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13
    • Domalpally A, Peng Q, Danis R, Blodi B, Scott IU, Ip M; SCORE Study Research Group: Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13. Eye (Lond) 2012; 26: 919-924.
    • (2012) Eye (Lond) , vol.26 , pp. 919-924
    • Domalpally, A.1    Peng, Q.2    Danis, R.3    Blodi, B.4    Scott, I.U.5    Ip, M.6
  • 53
    • 38449111578 scopus 로고    scopus 로고
    • Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions
    • Jonas JB, Rensch F: Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions. Br J Ophthalmol 2007; 91: 1711-1712.
    • (2007) Br J Ophthalmol , vol.91 , pp. 1711-1712
    • Jonas, J.B.1    Rensch, F.2
  • 54
    • 69249217805 scopus 로고    scopus 로고
    • Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular agerelated macular degeneration
    • Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ: Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular agerelated macular degeneration. Ophthalmology 2009; 116: 1755-1761.
    • (2009) Ophthalmology , vol.116 , pp. 1755-1761
    • Papadopoulou, D.N.1    Mendrinos, E.2    Mangioris, G.3    Donati, G.4    Pournaras, C.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.